Año 2022 / Volumen 114 / Número 4
Editorial
Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease

191-194

DOI: 10.17235/reed.2022.8718/2022

Antonio Liguori, Mirko Zoncapè, Emmanuel A. Tsochatzis,

Resumen
In the last two decades, several non-invasive liver fibrosis tests have been introduced in clinical practice and transformed the investigation of patients with non-alcoholic fatty liver disease. In this editorial, we summarize the role of such tests in the management of patients with non-alcoholic fatty liver disease, focusing on their strengths and pitfalls in different clinical settings and scenarios.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology and Hepatology. 2018;15(1):11-20.
2. Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389-397.e10.
3. Taylor RS, Taylor RJ, Bayliss S, et al. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Gastroenterology. 2020;158(6):1611-1625.e12.
4. Berzigotti A, Tsochatzis E, Boursier J, et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. Journal of Hepatology. 2021;75(3):659-689.
5. McPherson S, Hardy T, Dufour JF, et al. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. The American journal of gastroenterology. 2017;112(5):740-751.
6. Liguori A, Ainora ME, Riccardi L, et al. The role of elastography in non-alcoholic fatty liver disease. Minerva gastroenterology. 2021;67(2):164-170.
7. Miele L, Zocco MA, Pizzolante F, et al. Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease. Metabolism: Clinical and Experimental. 2020;112.
8. Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology. 2017;66(5):1486-1501.
9. Majumdar A, Campos S, Gurusamy K, et al. Defining the Minimum Acceptable Diagnostic Accuracy of Noninvasive Fibrosis Testing in Cirrhosis: A Decision Analytic Modeling Study. Hepatology (Baltimore, Md). 2020;71(2):627-642.
10. Tsochatzis EA, Newsome PN. Non-alcoholic fatty liver disease and the interface between primary and secondary care. The lancet Gastroenterology & hepatology. 2018;3(7):509-517.
11. Vali Y, Lee J, Boursier J, et al. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis. Journal of hepatology. 2020;73(2):252-262.
12. Srivastava A, Gailer R, Tanwar S, et al. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. Journal of Hepatology. 2019;71(2):371-378.
13. de Franchis R, Abraldes JG, Bajaj J, et al. Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. Journal of Hepatology. 2015;63(3):743-752.
14. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2021 Dec 30:S0168-8278(21)02299-6.
15. Papatheodoridi M, Hiriart JB, Lupsor-Platon M, et al. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. Journal of Hepatology. 2021;74(5):1109-1116.
16. Petta S, Sebastiani G, Bugianesi E, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. Journal of hepatology. 2018;69(4):878-885.
17. Pons M, Augustin S, Scheiner B, et al. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. The American journal of gastroenterology. 2021;116(4):723-732.
18. Thiele M, Hugger MB, Kim Y, et al. 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis. Liver Int. 2020 Jun;40(6):1435-1446.
19. Siddiqui MS, Yamada G, Vuppalanchi R, et al. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1877-1885.e5
20. Petta S, Sebastiani G, Viganò M, et al. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease. Clin Gastroenterol Hepatol. 2021 Apr;19(4):806-815.e5.
21. Younes R, Caviglia GP, Govaere O, et al. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 2021;75(4):786-794.
22. Francque SM, Bedossa P, Ratziu V, et al. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. New England Journal of Medicine. 2021;385(17):1547-1558.
23. Rinella ME, Dufour JF, Anstee QM, et al. Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study. J Hepatol. 2021 Nov 15:S0168-8278(21)02177-2.
24. Newsome PN, Buchholtz K, Cusi K, et al. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. New England Journal of Medicine. 2021;384(12):1113-1124.
25. Parkes J, Roderick P, Harris S, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut. 2010;59(9):1245-1251.
Artículos relacionados

Editorial

Tratamiento de la trombosis venosa portal en el paciente con cirrosis

DOI: 10.17235/reed.2023.9800/2023

Carta

Tolvaptan in portal hypertension: real life experience

DOI: 10.17235/reed.2022.9145/2022

Editorial

New actors come into play against hepatitis delta

DOI: 10.17235/reed.2022.9050/2022

Carta

Hemoperitoneo por rotura de varices intraabdominales

DOI: 10.17235/reed.2022.8937/2022

Imagen en Patología Digestiva

Fístula arterioportal traumática de alto flujo. Corrección mediante stent recubierto

DOI: 10.17235/reed.2022.8724/2022

Carta

Patrón cirrótico en la sarcoidosis hepática avanzada

DOI: 10.17235/reed.2021.8446/2021

Imagen en Patología Digestiva

Hepatocarcinoma quístico gigante en ausencia de cirrosis

DOI: 10.17235/reed.2021.8313/2021

Revisión

La fragilidad física en el contexto del trasplante hepático

DOI: 10.17235/reed.2020.7448/2020

Imagen en Patología Digestiva

Spontaneous splenoazygos shunt in a patient with portal hypertension: an exceedingly rare occurrence

DOI: 10.17235/reed.2019.6091/2018

Carta al Editor

Hipertensión portal idiopática por tiopurinas

DOI: 10.17235/reed.2018.5256/2017

Carta al Editor

POEMS syndrome and idiopathic portal hypertension: a possible association

DOI: 10.17235/reed.2017.4623/2016

Original

Self-expanding metal stents in postoperative esophageal leaks

DOI: 10.17235/reed.2016.3987/2015

Instrucciones para citar
Liguori A, Zoncapè M, Tsochatzis E. Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease. 8718/2022


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 1396 veces.
Este artículo ha sido descargado 411 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 15/02/2022

Aceptado: 16/02/2022

Prepublicado: 21/02/2022

Publicado: 07/04/2022

Tiempo de prepublicación: 6 días

Tiempo de edición del artículo: 51 días


Compartir
Este artículo ha sido valorado por 4 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas